Summary
Three placebo-controlled double-blind studies in healthy volunteers were performed to reveal the psychophysiological effects of scopolamine, ephedrine and their combination. Single intravenous dose of scopolamine 6 µg/kg (scopolamine hydrobromide 7.4 µg/kg) impaired various psychomotor functions both subjectively and objectively. It caused sedation, impairment of coordinative and reactive skills, visual disturbances and impairment of short-term memory. Oral scopolamine hydrobromide in single doses of 0.3 mg and 0.9 mg, or 0.9 mg b.d. for 3 days, had few effects. A slight impairment of short-term memory and a decrease in the flicker fusion threshold were seen. The visual nearpoint and pupil diameter were increased and some subjects reported blurred vision and dizziness during treatment with scopolamine 0.9 mg b.d. Scopolamine showed clear cardiovascular effects in all studies: it decreased heart rate and systolic blood pressure. Ephedrine alone and in combination with scopolamine had no deleterious effects. On the contrary, it antagonized the scopolamine-induced impairment in the flicker fusion test and the decrease in blood pressure and heart rate. In sufficient doses scopolamine impairs various psychomotor and cognitive skills. An oral dose of scopolamine hydrobromide 0.9 mg on average has few effects, although they may be very striking in certain individuals. To avoid unwanted effects and diminition in performance by scopolamine, doses less than 0.9 mg should be used.
Similar content being viewed by others
References
Wood CD, Graybiel A (1970) A theory of motion sickness based on pharmacological reactions. Clin Pharmacol Ther 11: 621–629
Graybiel A, Knepton J, Shaw J (1976) Prevention of experimental motion sickness by scopolamine absorbed through the skin. Aviat Space Environ Med 47: 1096–1100
Wood C (1979) Antimotion sickness and antiemetic drugs. Drugs 17: 471–479
Weiner N (1980) Atropine, scopolamine, and related antimuscarinic drugs. In: Goodman LS, Gilman A (eds) The Pharmacological basis of therapeutics. Macmillan, New York
Hindmarch I (1980) Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 10: 189–209
Liljequist R, Mattila MJ (1979) Effect of physostigmine and scopolamine on the memory functions of chess players. Med Biol 57: 402–405
Linnoila M, Mattila MJ (1973) Drug interactions on psychomotor skills related to driving: Diazepam and alcohol. Eur J Clin Pharmacol 5: 186–194
Lahtinen U, Lahtinen A, Pekkola P (1978) The effect of nitrazepam on manual skill, grip strength and reaction time with special reference to subjective evaluation of effects on sleep. Acta Pharmacol Toxicol 42: 130–134
Maruyama K, Kitamura S (1961) Speed anticipation test: A test for discrimination of accident proness in motor driver. Tohoku Psychol Folia 20: 13–20
Savolainen K, Linnavuo M (1979) Effects of m-xylene on human equilibrium measured with a quantitative method. Acta Pharmacol Toxicol 44: 315–318
Simonson E, Brozek J (1952) Flicker fusion frequency. Background and applications. Physiol Rev 32: 349–378
Hannington-Kiff JG (1970) Measurement of recovery from outpatient general anaesthesia with simple ocular test. Br Med J 3: 132–135
Lehti HMJ (1976) The effect of blood alcohol concentration on the onset of gaze nystagmus. Blutalkohol 13: 411–414
Hilgard ER (1951) Methods and procedures in the study of learning. In: Steven SS (ed) Handbook of experimental psychology. Wiley, New York, pp 517–567
Liljequist R, Seppälä T, Mattila MJ (1978) Amitriptyline-and mianserin-induced changes in acquisition of paired-association learning-task. Br J Clin Pharmacol 5: 149–153
Wechsler D (1944) Measurement of adult intelligence. Williams and Wilkins, Baltimore, USA
Hänninen H (1971) Psychological picture of manifest and latent carbon disulphide poisoning. Br J Ind Med 28: 374–381
Seppälä T (1981) The effects of atropine on psychomotor skills. In: Goldberg L (ed) Alcohol, drugs and traffic safety, Vol III. Almquist Wiksell International, Stockholm, Sweden
Safer DJ, Allen RP (1971) The central effects of scopolamine in man. Biol Psychiatry 3: 347–355
Ghoneim MM, Mewaldt SP (1975) Effects of diazepam and scopolamine on storage, retrieval and organizational process in memory. Psychopharmacologia (Berl) 44: 257–262
Sitaram N, Weingartner H, Gillin JC (1978) Human serial learning: Enhancement with arecholine and choline and impairment with scopolamine. Science 201: 274–276
Petersen RC (1977) Scopolamine induced learning failures in man. Psychopharmacology (Berlin) 52: 283–289
Frumin MJ, Herekar VR, Jarvik ME (1976) Amnesic actions of diazepam and scopolamine in man. Anesthesiology 45: 406–412
Nuotto E, Mattila MJ, Seppälä T, Konno K (1984) Coffee and caffeine and alcohol effects on psychomotor function. Clin Pharmacol Ther 31: 68–76
Mattila MJ, Palva E, Savolainen K (1982) Caffeine antagonizes diazepam effects in man. Med Biol 60: 121–123
Shutt LE, Bowes JB (1979) Atropine and hyoscine. Anaesthesia 34: 476–490
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nuotto, E. Psychomotor, physiological and cognitive effects of scopolamine and ephedrine in healthy man. Eur J Clin Pharmacol 24, 603–609 (1983). https://doi.org/10.1007/BF00542208
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542208